App Note: Bring Product Quality Assessment into Early Clone Selection with the Opto™ Assure Aggregation Assay
Read this application note to learn more about how to get early, multi-parameter assessment of clones with the Opto Assure assay series.
Related Resources
View All ResourcesProduct Tour: The Opto™ CLD Workflow
Antibody expert, Anupam Singhal, PhD, does a 10-minute walkthrough of how the Opto™ CLD workflow makes it possible to produce superior cell lines, with >99% monoclonality assurance, in a matter of days.
DATASHEET: Opto® Cell Line Development Workflow | A4
- Selective Cell Cloning for better clones and accelerated campaign timelines
- Custom Productivity Assay for selection of cell lines expressing a wide range of therapeutic proteins and vaccines
APP NOTE: Identify Top Producing Clones with Favorable Product Quality Attributes
- Identify clones with favorable growth, titer, and product quality attributes prior to scale up
- Go from transfected pools to top clones in under one week for a wide variety of protein therapeutics, including protein-based vaccines,
enzymes and bispecific molecules - Cloning efficiencies 5x greater than FACS and 10x greater than limiting dilution, and >99% monoclonality assurance